Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

A medical team at the Amsterdam University Medical Centre (AUMC) in the Netherlands completed the first-in-human ventricular ...

(Company or Imricor) (ASX: IMR) is pleased to announce that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time MRI with the Company ...

Field Medical Inc. reaped $40 million in its series A fundraising via $20 million in new capital and conversion of $20 ...

Pulmonary embolism (PE) is a significant cause of morbidity and mortality, particularly in patients classified as acute, ...

Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of $40 million in Series A financing. The round includes $20 million in new ...

Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of ...

Shares of Adagio Medical Holdings, Inc. (ADGM) experienced a significant surge in retail investor interest last week as they ...

Imricor Medical Systems announced that it commenced a trial by completing its first-in-human ventricular ablation procedure.

Adagio Medical (ADGM) announced it received Breakthrough Device designation from the FDA for its vCLAS Cryoablation System. The designation is ...